Managing the Spectrum of Behavioral Health Disorders Enduring Webcast: Collaborating to Improve Patient Outcomes
Release date: 10 August, 2009
Expiration date: 31st January, 2011
Estimated time to complete activity: 2 hours
Target Audience
This activity has been designed to meet the educational needs of physicians, pharmacists, and registered nurses practicing in a managed behavioral health care setting.
Purpose Statement
This activity will help providers in a managed behavioral health care setting to: (1) assess evidence-based outcomes associated with the diagnosis, psychotherapy, and pharmacotherapy for schizophrenia, depression, and bipolar disorder; and (2) develop collaborative care strategies to implement practical steps to improve outcomes in patients who require behavioral health treatment for these conditions.
Statement of Need/Program Overview
In today’s health care environment, providers practicing in a managed behavioral health care setting are challenged by the need to effectively diagnose and treat patients with a variety of behavioral health disorders within a framework that ensures quality of care while balancing economic outcomes. These challenges include the management of multifaceted disorders such as schizophrenia, bipolar disorder, and depression. In recent years, the rise of managed behavioral health care has placed added strain on an already over burdened United States health care system. Because of the complex nature and overlap of various behavioral health disorders, there is a need to increase the comfort to select appropriate pharmacologic and non-pharmacologic treatment options and provide instruction on a collaborative care approach to patient care.
Educational Objectives
After completing this activity, the participant should be better able to:
- Review new data on the pathophysiology of psychiatric illnesses, including schizophrenia, depression, and other bipolar disorders
- Review advancements in treatment of these three psychiatric illnesses, including the impact on patient outcomes
- Identify improvements in the diagnosis of these illnesses
- Describe an evidence-based treatment plan that utilizes pharmacologic and non-pharmacologic strategies to improve patient outcomes for these three psychiatric illnesses
- Describe collaborative care techniques to the evidence-based treatment plan for this complex behavioral health patient population
| Faculty Mark B. Hamner, MD Professor, Department of Psychiatry and Behavioral Sciences Medical University of South Carolina Charleston, South Carolina Click here for bio |
 |
| David K. Nace, MD Principal Health Strategy Solutions, LLC Bryn Mawr, PA Click here for bio |
 |
| Charles Raison, MD Assistant Professor Director, Behavioral Immunology Clinic Emory University Department of Psychiatry and Behavioral Sciences Atlanta, GA Click here for bio |
 |
| Mark Townsend, MD Professor and Vice Chair for General Psychiatry Department of Psychiatry Louisiana State University Health Sciences Center New Orleans, LA Click here for bio |
 |
Activity Agenda
Review of Objectives
David K. Nace, MD
Schizophrenia Treatment Strategies: A Systematic Approach to Selecting the Right
Treatment Plan
Mark Hamner, MD
Depression Management: What We Now Know and Where We Should Go
Charles Raison, MD
Getting to the Correct Diagnosis and Treatment of Bipolar Disorder Earlier
Mark Townsend, MD
Implementing a Collaborative Care Plan to Improve Patient Outcomes
David K. Nace, MD
Question and Answer Session
Faculty Panel
Post-Activity Survey and Evaluation Completion
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Postgraduate Institute for Medicine (PIM) and Impact Education, LLC. PIM is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
Postgraduate Institute for Medicine designates this educational activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Pharmacist Accreditation Statement
Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Credit Designation
Postgraduate Institute for Medicine designates this continuing education activity for 2.0 contact hours (0.20 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number – 809-999-09-039-H01-P). Please note that if you received credit for UAN 809-999-09-039-L01-P, you are not eligible for this activity.
Nursing Accreditation Statement
This educational activity for 2.0 contact hours is provided by Postgraduate Institute for Medicine (PIM).
Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be mailed to you within 3 weeks.
Fee Information
There is no fee for this educational activity.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
|
|||||||||||||||||||
Method of Participation There are no fees for participating and receiving CME credit for this activity. During the period -- August, 2009 through January 31st, 2011, participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; 3) complete the posttest online or record the best answer to each question in the answer key on the evaluation form; 4) complete the evaluation form; and 5) submit the form electronically or fax the evaluation form with answer key to Postgraduate Institute for Medicine. A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed posttest with a score of 70% or better. If you submit an evaluation online, you will receive your certificate electronically. If you submit an evaluation via fax, your certificate will be mailed to you within 3 weeks. Media Internet Disclosure of Unlabeled Use The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, Impact Education, and Bristol-Myers Squibb Company. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. |
|||||||||||||||||||